Glyclopyramide
Chemical compound
- none
- In general: ℞ (Prescription only)
- 4-chloro-N-[(pyrrolidin-1-ylamino)carbonyl]benzenesulfonamide
- 631-27-6
N
- 71793
- 64820 N
- KE474IKG1W
- D01799
Y
- ChEMBL2105083 N
- DTXSID2048822
- Interactive image
- C1CCN(C1)NC(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl
InChI
- InChI=1S/C11H14ClN3O3S/c12-9-3-5-10(6-4-9)19(17,18)14-11(16)13-15-7-1-2-8-15/h3-6H,1-2,7-8H2,(H2,13,14,16)N
- Key:HNSCCNJWTJUGNQ-UHFFFAOYSA-NN
N
Y (what is this?) (verify)Glyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.
It is classified as second generation.[1]
References
- ^ Ozawa H, Murai Y, Ozawa T (2003). "[A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus]". Yakugaku Zasshi (in Japanese). 38 (1): 11–27. PMID 14570054.
External links
- DEAMELIN·S Tablets 250 mg
- v
- t
- e
Oral diabetes medication, insulins and insulin analogs, and other drugs used in diabetes (A10)
| |||||||||||
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
